Ramandeep Kaur, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 10 carriers
- Offices
- 2
Offices
2 locations
Looking this up.
Plans that list them
33 plans · 10 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kaur’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A133059 · Current
Licensed to practise in California · since 2014 · expires 2028-09-30 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
12 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 76.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Appropriate Treatment for Upper Respiratory Infection (URI)As Medicare defines this measure | 66% | 531 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 45%That's less than half. | 437 |
| Breast cancer screeningEligible women who got a mammogram | 2%That's few of the people this applied to. | 1,467 |
| Childhood Immunization StatusAs Medicare defines this measure | 1% | 119 |
| Chlamydia Screening for WomenAs Medicare defines this measure | 15% | 490 |
| Colon cancer screeningEligible adults who got a colon cancer test | 3%That's few of the people this applied to. | 3,736 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 2%That's few of the people this applied to. | 279 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 77%That's most of the people this applied to. Worse on this measure. | 279 |
See the other 4 measures
| HIV screeningEligible patients who were screened for HIV | 7%That's few of the people this applied to. | 12,722 |
| Medications listed in the chartVisits where the current medication list was documented | 82%That's most of the people this applied to. | 22,257 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 1,418 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 33% | 17,853 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- Uses standard treatment protocols
Original Medicare doctor bills
$83,280
Medicare paid this office $83,280 for 637 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 267 | $37,171 | $70 |
| New patient visit (30+ min) | 252 | $18,615 | $74 |
| New patient visit (15+ min) | 168 | $8,365 | $50 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 103 | $3,877 | $35 |
| Short return visit | 60 | $3,334 | $46 |
See all 14 services
| Short return visit (20+ min) | 267 | $37,171 | $70 |
| New patient visit (30+ min) | 252 | $18,615 | $74 |
| New patient visit (15+ min) | 168 | $8,365 | $50 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 103 | $3,877 | $35 |
| Short return visit | 60 | $3,334 | $46 |
| Detection test by immunoassay with direct visual observation for influenza virus | 76 | $2,498 | $16 |
| Return visit (30+ min) | 26 | $2,067 | $79 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 52 | $891 | $16 |
| Injection of drug or substance under skin or into muscle | 30 | $470 | $12 |
| Automated urinalysis test | 78 | $224 | $2 |
| Removal of impacted ear wax by washing | 13 | $224 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $158 | $12 |
| Inhalation treatment for airway obstruction or sputum production | 20 | $154 | $7 |
| Injection, ketorolac tromethamine, per 15 mg | 11 | $19 | None |
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
| Removal of skin lesions | 20 | More than 65% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
637 Original Medicare patients in 2024. Average age 73 · Under 65 9% · 85 and older 11% · Women 64% · Also on Medicaid 20% · Health risk score 0.89. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 63% · Diabetes 24% · Coronary heart disease 18% · Depression 18% · Chronic kidney disease 14% · COPD 11% · Atrial fibrillation 11% · Cancer 10% · Heart failure 8% · Stroke 6% · Dementia 5%.
The office billed $257,013, Medicare allowed $127,164 and paid $83,280; for 1,762 services of 50 kinds; $349 of it was for drugs given in the office and $82,931 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 637 | 1,762 | 73 | 0.89 | $257,013 | $83,280 |
| 2023 | 865 | 2,248 | 72 | 0.90 | $362,043 | $134,744 |
| 2022 | 1,633 | 4,278 | 72 | 0.87 | $810,535 | $273,504 |
| 2021 | 1,349 | 3,380 | 71 | 0.81 | $550,315 | $285,804 |
| 2020 | 699 | 1,988 | 72 | 0.77 | $268,724 | $151,746 |
| 2019 | 455 | 1,222 | 73 | 0.90 | $166,027 | $83,123 |
| 2018 | 244 | 737 | 71 | 0.95 | $94,078 | $51,145 |
| 2017 | 185 | 539 | 69 | 0.79 | $65,556 | $36,406 |
| 2016 | 88 | 217 | 71 | 1.31 | $29,643 | $16,484 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| New patient visit (30+ min) | 621 | $56,485 | $91 |
| Short return visit (20+ min) | 342 | $46,852 | $74 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 107 | $5,531 | $50 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 144 | $5,401 | $35 |
| New patient visit (15+ min) | 52 | $3,114 | $60 |
| Detection test by immunoassay with direct visual observation for influenza virus | 87 | $2,871 | $16 |
| Short return visit | 54 | $2,531 | $43 |
| New patient visit (45+ min) | 14 | $1,867 | $133 |
| Return visit (30+ min) | 16 | $1,798 | $100 |
| Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less | 16 | $1,328 | $83 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 66 | $1,102 | $16 |
| Removal of impacted ear wax | 17 | $682 | $38 |
| Injection of drug or substance under skin or into muscle | 17 | $274 | $12 |
| Automated urinalysis test | 66 | $176 | $2 |
| Inhalation treatment for airway obstruction or sputum production | 14 | $107 | $7 |
| Injection, ketorolac tromethamine, per 15 mg | 11 | $7 | None |
2022: 13 services
| New patient visit (15+ min) | 972 | $80,868 | $83 |
| New patient visit (30+ min) | 366 | $38,908 | $106 |
| Short return visit | 337 | $36,593 | $64 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 765 | $34,885 | $35 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 537 | $32,226 | $51 |
| Short return visit (20+ min) | 243 | $30,310 | $86 |
| Return visit (30+ min) | 42 | $8,731 | $121 |
| New patient visit (45+ min) | 21 | $3,177 | $151 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,710 | $155 |
| Detection test by immunoassay with direct visual observation for influenza virus | 47 | $1,461 | $16 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $486 | $27 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 19 | $324 | $16 |
| Automated urinalysis test | 39 | $104 | $2 |
2021: 10 services
| New patient visit (30+ min) | 734 | $91,733 | $125 |
| Return visit (30+ min) | 201 | $46,084 | $138 |
| New patient visit (15+ min) | 423 | $35,767 | $85 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 578 | $32,941 | $51 |
| Short return visit (20+ min) | 194 | $30,567 | $96 |
| Short return visit | 236 | $19,863 | $68 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 353 | $14,627 | $35 |
| New patient visit (45+ min) | 53 | $7,929 | $150 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,409 | $161 |
| Automated urinalysis test | 30 | $70 | $2 |
2020: 12 services
| New patient visit (30+ min) | 549 | $60,066 | $109 |
| Return visit (30+ min) | 171 | $32,309 | $99 |
| Short return visit | 250 | $20,263 | $56 |
| Short return visit (20+ min) | 126 | $15,118 | $77 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 164 | $9,133 | $51 |
| New patient visit (45+ min) | 46 | $6,928 | $151 |
| Detection test by immunoassay with direct visual observation for influenza virus | 24 | $719 | $16 |
| Injection of drug or substance under skin or into muscle | 25 | $322 | $12 |
| Inhalation treatment for airway obstruction or sputum production | 13 | $262 | $15 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 11 | $178 | $16 |
| Automated urinalysis test | 32 | $80 | $2 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 13 | $2 | None |
2019: 12 services
| Return visit (30+ min) | 153 | $29,296 | $95 |
| New patient visit (30+ min) | 242 | $21,040 | $87 |
| New patient visit (45+ min) | 158 | $17,389 | $110 |
| Short return visit (20+ min) | 40 | $3,054 | $66 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,526 | $139 |
| Detection test by immunoassay with direct visual observation for influenza virus | 24 | $811 | $16 |
| Removal of impacted ear wax | 16 | $803 | $45 |
| Injection of drug or substance under skin or into muscle | 36 | $638 | $16 |
| Inhalation treatment for airway obstruction or sputum production | 24 | $538 | $19 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 18 | $292 | $16 |
| Automated urinalysis test | 51 | $161 | $2 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 25 | $3 | None |
2018: 10 services
| Return visit (30+ min) | 112 | $22,458 | $92 |
| New patient visit (45+ min) | 110 | $13,362 | $121 |
| New patient visit (30+ min) | 92 | $8,016 | $87 |
| Short return visit (20+ min) | 19 | $1,416 | $64 |
| Injection of drug or substance under skin or into muscle | 25 | $638 | $19 |
| Inhalation treatment for airway obstruction or sputum production | 19 | $579 | $19 |
| Detection test by immunoassay with direct visual observation for influenza virus | 14 | $454 | $16 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 16 | $259 | $16 |
| Automated urinalysis test | 20 | $65 | $2 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 19 | $3 | None |
2017: 6 services
| Return visit (30+ min) | 78 | $15,834 | $93 |
| New patient visit (45+ min) | 71 | $8,111 | $114 |
| New patient visit (30+ min) | 93 | $6,796 | $73 |
| Short return visit (20+ min) | 13 | $876 | $58 |
| Injection of drug or substance under skin or into muscle | 17 | $548 | $23 |
| Urinalysis, manual test | 23 | $89 | $3 |
2016: 3 services
| Return visit (30+ min) | 27 | $6,011 | $94 |
| New patient visit (45+ min) | 48 | $5,316 | $111 |
| New patient visit (30+ min) | 31 | $2,625 | $85 |
Medicaid work
$77,649 in 2024
Medicaid paid $77,649 for 3,010 billed services this clinician did in 2024, up to 144 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 952 | $36,989 |
| New patient visit (30+ min) | 656 | $20,573 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 439 | $10,259 |
| Short return visit | 132 | $5,505 |
| SARSCOV CORONAVIRUS AG IA | 254 | $2,901 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 290 | $973 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 195 | $318 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 39 | $112 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 53 | $18 |
| 2024 | 3,010 | 9 | 144 | $77,649 |
| 2023 | 5,408 | 12 | 227 | $162,227 |
| 2022 | 4,371 | 11 | 414 | $134,206 |
| 2021 | 1,451 | 8 | 176 | $39,164 |
| 2020 | 233 | 6 | 38 | $3,503 |
See the largest Medicaid services in earlier years
2023
| New patient visit (30+ min) | 1,741 | $75,179 |
| Short return visit (20+ min) | 2,011 | $73,353 |
| Short return visit | 77 | $4,745 |
| SARSCOV CORONAVIRUS AG IA | 329 | $4,084 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 34 | $2,064 |
| Return visit (30+ min) | 27 | $1,320 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 315 | $750 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 251 | $357 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 17 | $307 |
| Service(s) provided in the office during regularly scheduled evening, weekend, or holiday office hours, in addition to basic service | 424 | $26 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 154 | $23 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 28 | $19 |
2022
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 796 | $31,687 |
| New patient visit (30+ min) | 440 | $24,784 |
| SARSCOV CORONAVIRUS AG IA | 1,319 | $22,805 |
| Short return visit (20+ min) | 323 | $15,914 |
| Short return visit | 488 | $12,824 |
| OFF/OP EST MAY X REQ PHY/QHP | 197 | $9,999 |
| Services provided in an urgent care center (list in addition to code for service) | 95 | $8,429 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 331 | $6,612 |
| Return visit (30+ min) | 28 | $1,064 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 61 | $53 |
| Service(s) provided in the office during regularly scheduled evening, weekend, or holiday office hours, in addition to basic service | 293 | $35 |
2021
| New patient visit (30+ min) | 586 | $24,020 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 262 | $5,051 |
| SARSCOV CORONAVIRUS AG IA | 336 | $4,378 |
| Return visit (30+ min) | 123 | $2,985 |
| Short return visit (20+ min) | 27 | $1,761 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 17 | $605 |
| Short return visit | 44 | $351 |
| Service(s) provided in the office during regularly scheduled evening, weekend, or holiday office hours, in addition to basic service | 56 | $14 |
2020
| New patient visit (30+ min) | 80 | $2,370 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 29 | $667 |
| Short return visit | 31 | $241 |
| Short return visit (20+ min) | 32 | $218 |
| Service(s) provided in the office during regularly scheduled evening, weekend, or holiday office hours, in addition to basic service | 27 | $7 |
| Services provided in an urgent care center (list in addition to code for service) | 34 | $0 |
Drugs they prescribed that Part D paid
$34,275
Pharmacies billed $34,275 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
695 generic and fewer than 11 brand-name prescriptions · $34,275 in drug cost · 54 antibiotic prescriptions to 45 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lantus Solostar | 11 | $1,202 | $109 |
| Atorvastatin | 64 | $337 | $5 |
| Metformin | 32 | $320 | $10 |
| Tamsulosin | 28 | $301 | $11 |
| Losartan | 34 | $254 | $7 |
See all 16 drugs
| Lantus Solostar | 11 | $1,202 | $109 |
| Atorvastatin | 64 | $337 | $5 |
| Metformin | 32 | $320 | $10 |
| Tamsulosin | 28 | $301 | $11 |
| Losartan | 34 | $254 | $7 |
| Levothyroxine | 20 | $243 | $12 |
| Albuterol Sulfate Hfa | 14 | $237 | $17 |
| Fluticasone Propionate | 28 | $201 | $7 |
| Gabapentin | 26 | $162 | $6 |
| Amlodipine Besylate | 33 | $146 | $4 |
| Lisinopril | 19 | $136 | $7 |
| Trazodone | 19 | $88 | $5 |
| Cephalexin | 20 | $87 | $4 |
| Azithromycin | 14 | $26 | $2 |
| Atenolol | 12 | $17 | $1 |
| Hydrochlorothiazide | 19 | $15 | $1 |
Year by year
| 2024 | 758 | 148 | None | None | $34,275 |
| 2023 | 893 | 153 | 1% (12) | 9% | $70,103 |
| 2022 | 1,056 | 165 | 1% (11) | 10% | $59,523 |
| 2021 | 1,222 | 151 | 2% (22) | 11% | $94,755 |
| 2020 | 1,126 | 153 | 3% (30) | 13% | $87,099 |
| 2019 | 782 | 161 | 2% (12) | None | $40,024 |
| 2018 | 681 | 137 | 3% (17) | None | $33,832 |
| 2017 | 548 | 111 | 7% (40) | 14% | $22,358 |
| 2016 | 272 | 82 | 12% (32) | 10% | $11,427 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Atorvastatin | 62 | $1,302 | $21 |
| Metformin | 54 | $992 | $18 |
| Losartan | 43 | $735 | $17 |
| Albuterol Sulfate Hfa | 16 | $449 | $28 |
| Gabapentin | 32 | $447 | $14 |
| Baclofen | 12 | $356 | $30 |
| Omeprazole | 23 | $329 | $14 |
| Levothyroxine | 24 | $315 | $13 |
| Amlodipine Besylate | 22 | $290 | $13 |
| Famotidine | 14 | $288 | $21 |
| Glyburide | 12 | $254 | $21 |
| Tamsulosin | 16 | $185 | $12 |
| Carvedilol | 11 | $170 | $15 |
| Cephalexin | 18 | $163 | $9 |
| Fluticasone Propionate | 16 | $163 | $10 |
| Simvastatin | 11 | $151 | $14 |
| Glipizide | 17 | $126 | $7 |
| Hydrochlorothiazide | 21 | $114 | $5 |
| Meloxicam | 17 | $95 | $6 |
| Azithromycin | 15 | $95 | $6 |
| Trazodone | 16 | $87 | $5 |
| Triamcinolone Acetonide | 14 | $84 | $6 |
| Donepezil | 13 | $71 | $5 |
| Atenolol | 12 | $50 | $4 |
| Prednisone | 13 | $21 | $2 |
2022: 28 drugs
| Qvar Redihaler | 13 | $3,630 | $279 |
| Atorvastatin | 98 | $1,394 | $14 |
| Albuterol Sulfate Hfa | 21 | $789 | $38 |
| Metformin | 70 | $721 | $10 |
| Losartan | 53 | $568 | $11 |
| Glyburide | 12 | $350 | $29 |
| Lisinopril | 25 | $350 | $14 |
| Gabapentin | 29 | $341 | $12 |
| Amlodipine Besylate | 48 | $337 | $7 |
| Levothyroxine | 15 | $320 | $21 |
| Metoprolol | 15 | $267 | $18 |
| Tamsulosin | 19 | $250 | $13 |
| Omeprazole | 18 | $232 | $13 |
| Fluticasone Propionate | 27 | $226 | $8 |
| Cephalexin | 24 | $211 | $9 |
| Trazodone | 20 | $192 | $10 |
| Carvedilol | 15 | $185 | $12 |
| Cyclobenzaprine | 16 | $165 | $10 |
| Alendronate | 11 | $151 | $14 |
| Famotidine | 13 | $114 | $9 |
| Donepezil | 14 | $86 | $6 |
| Triamcinolone Acetonide | 14 | $75 | $5 |
| Azithromycin | 11 | $69 | $6 |
| Glipizide | 12 | $66 | $6 |
| Simvastatin | 11 | $56 | $5 |
| Furosemide | 14 | $56 | $4 |
| Hydrochlorothiazide | 12 | $54 | $4 |
| Prednisone | 13 | $26 | $2 |
2021: 29 drugs
| Humulin 70/30 Kwikpen | 11 | $11,937 | $1,085 |
| Levemir Flextouch | 12 | $3,584 | $299 |
| Atorvastatin | 129 | $2,116 | $16 |
| Losartan | 63 | $960 | $15 |
| Gabapentin | 41 | $780 | $19 |
| Levothyroxine | 27 | $711 | $26 |
| Metformin | 72 | $667 | $9 |
| Albuterol Sulfate Hfa | 12 | $494 | $41 |
| Lisinopril | 39 | $473 | $12 |
| Amlodipine Besylate | 62 | $459 | $7 |
| Glyburide | 13 | $328 | $25 |
| Omeprazole | 17 | $296 | $17 |
| Metoprolol | 20 | $231 | $12 |
| Simvastatin | 20 | $202 | $10 |
| Cyclobenzaprine | 21 | $184 | $9 |
| Carvedilol | 14 | $166 | $12 |
| Famotidine | 17 | $163 | $10 |
| Fluticasone Propionate | 14 | $141 | $10 |
| Tamsulosin | 11 | $137 | $12 |
| Vitamin D2 | 17 | $137 | $8 |
| Atenolol | 12 | $121 | $10 |
| Glipizide | 17 | $115 | $7 |
| Furosemide | 25 | $112 | $4 |
| Sumatriptan | 12 | $99 | $8 |
| Ibuprofen | 11 | $90 | $8 |
| Hydrochlorothiazide | 14 | $76 | $5 |
| Cephalexin | 13 | $56 | $4 |
| Prednisone | 17 | $33 | $2 |
| Tramadol | 12 | $18 | $1 |
2020: 24 drugs
| Atorvastatin | 107 | $1,849 | $17 |
| Albuterol Sulfate Hfa | 28 | $1,219 | $44 |
| Levothyroxine | 32 | $802 | $25 |
| Amlodipine Besylate | 71 | $595 | $8 |
| Gabapentin | 35 | $443 | $13 |
| Losartan | 31 | $413 | $13 |
| Metformin | 50 | $382 | $8 |
| Fluticasone Propionate | 29 | $343 | $12 |
| Lisinopril | 15 | $216 | $14 |
| Atenolol | 19 | $193 | $10 |
| Famotidine | 14 | $181 | $13 |
| Metoprolol | 16 | $176 | $11 |
| Hydroxyzine | 17 | $169 | $10 |
| Glipizide | 20 | $144 | $7 |
| Hydrocodone-Acetaminophen | 12 | $130 | $11 |
| Cephalexin | 22 | $126 | $6 |
| Omeprazole | 12 | $117 | $10 |
| Simvastatin | 21 | $114 | $5 |
| Hydrochlorothiazide | 17 | $94 | $6 |
| Furosemide | 16 | $87 | $5 |
| Cyclobenzaprine | 15 | $84 | $6 |
| Citalopram Hbr | 13 | $63 | $5 |
| Tramadol | 14 | $45 | $3 |
| Prednisone | 15 | $33 | $2 |
2019: 21 drugs
| Atorvastatin | 57 | $1,075 | $19 |
| Albuterol Sulfate Hfa | 20 | $975 | $49 |
| Gabapentin | 40 | $858 | $21 |
| Levothyroxine | 23 | $657 | $29 |
| Ventolin Hfa | 11 | $617 | $56 |
| Amlodipine Besylate | 39 | $424 | $11 |
| Metformin | 36 | $331 | $9 |
| Fluticasone Propionate | 21 | $272 | $13 |
| Lisinopril | 13 | $253 | $19 |
| Losartan | 22 | $222 | $10 |
| Atenolol | 12 | $222 | $18 |
| Citalopram Hbr | 12 | $219 | $18 |
| Ranitidine | 13 | $213 | $16 |
| Azithromycin | 25 | $177 | $7 |
| Simvastatin | 15 | $155 | $10 |
| Amoxicillin-Clavulanate Potass | 12 | $141 | $12 |
| Triamcinolone Acetonide | 12 | $140 | $12 |
| Cephalexin | 18 | $110 | $6 |
| Hydrochlorothiazide | 16 | $76 | $5 |
| Sulfamethoxazole-Trimethoprim | 17 | $68 | $4 |
| Prednisone | 12 | $37 | $3 |
2018: 17 drugs
| Proair Hfa | 24 | $1,410 | $59 |
| Ventolin Hfa | 24 | $1,324 | $55 |
| Ondansetron Odt | 13 | $876 | $67 |
| Atorvastatin | 33 | $744 | $23 |
| Levothyroxine | 27 | $615 | $23 |
| Gabapentin | 22 | $416 | $19 |
| Metformin | 36 | $326 | $9 |
| Amlodipine Besylate | 25 | $314 | $13 |
| Losartan | 24 | $243 | $10 |
| Carvedilol | 15 | $211 | $14 |
| Atenolol | 14 | $209 | $15 |
| Lisinopril | 11 | $191 | $17 |
| Fluticasone Propionate | 14 | $179 | $13 |
| Glipizide | 12 | $149 | $12 |
| Simvastatin | 17 | $144 | $8 |
| Azithromycin | 17 | $127 | $7 |
| Cephalexin | 11 | $69 | $6 |
2017: 13 drugs
| Proair Hfa | 18 | $1,066 | $59 |
| Atorvastatin | 29 | $470 | $16 |
| Levothyroxine | 18 | $339 | $19 |
| Azithromycin | 26 | $143 | $6 |
| Metformin | 16 | $136 | $8 |
| Carvedilol | 13 | $117 | $9 |
| Simvastatin | 17 | $98 | $6 |
| Amlodipine Besylate | 14 | $97 | $7 |
| Hydrocodone-Acetaminophen | 17 | $94 | $6 |
| Cephalexin | 14 | $79 | $6 |
| Ibuprofen | 12 | $72 | $6 |
| Lisinopril | 15 | $67 | $4 |
| Tramadol | 12 | $54 | $5 |
2016: 3 drugs
| Gabapentin | 14 | $109 | $8 |
| Azithromycin | 11 | $75 | $7 |
| Prednisone | 17 | $75 | $4 |
Money from drug and device companies
$79 in 2025
| 2025 | 3 | 3 | None | $79 |
| 2024 | 2 | 4 | None | $133 |
| 2023 | 2 | 3 | None | $67 |
| 2022 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| TerSera Therapeutics | Xermelo | $33 | 1 payment
|
| Abbvie | Rinvoq | $27 | 1 payment
|
| bioMerieux | None | $20 | 1 payment
|
See all 3 published payments
| bioMerieux | Meals · 2025-12-11 | None | $20 |
| Abbvie | Meals · 2025-03-13 | Rinvoq | $27 |
| TerSera Therapeutics | Meals · 2025-03-12 | Xermelo | $33 |
See earlier years (2024, 2023, 2022)
2024: $133
| Kestra Medical Technology Services | Assure Wcd | $104 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $30 | 2 payments
|
2023: $67
| Abbvie | Rinvoq | $52 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $15 | 1 payment
|
2022: $20
| MannKind | Afrezza | $20 | 1 payment
|
Professional record
- NPI
- 1710313259
- Licence
- CA A133059California A133059: Current · expires 2028-09-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 5138 Monterey Hwy, Suite G, San Jose, CA, 95111
- NPI first listed
- 2013-09-16
- NPI last updated
- 2024-08-08
- NPI record certified
- 2024-08-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5138 Monterey Hwy, San Jose, CA, 95111 · 4949 Stevens Creek Blvd, Santa Clara, CA, 95051 · 970 W El Camino Real Ste 8, Sunnyvale, CA, 94087